Abstract

To reduce the incidence of tuberculosis, it is insufficient to simply understand the dynamics of tuberculosis transmission. Rather, we must design and rigorously evaluate interventions to halt transmission, prioritizing those interventions most likely to achieve population-level impact. Synergy in reducing tuberculosis transmission may be attainable by combining interventions that shrink the reservoir of latent Mycobacterium tuberculosis infection (preventive therapy), shorten the time between disease onset and treatment initiation (case finding and diagnosis), and prevent transmission in key settings, such as the built environment (infection control). In evaluating efficacy and estimating population-level impact, cluster-randomized trials and mechanistic models play particularly prominent roles. Historical and contemporary evidence suggests that effective public health interventions can halt tuberculosis transmission, but an evidence-based approach based on knowledge of local epidemiology is necessary for success. We provide a roadmap for designing, evaluating, and modeling interventions to interrupt the process of transmission that fuels a diverse array of tuberculosis epidemics worldwide.

Highlights

  • Over the past 15 years, the number of deaths due to tuberculosis has fallen by 22%, but the annual number of incident cases of tuberculosis has remained the same (Figure 1) [1]

  • We provide a roadmap for designing, evaluating, and modeling interventions to halt tuberculosis transmission and interrupt the underlying process fueling the diverse array of tuberculosis epidemics worldwide

  • The highest tuberculosis incidence rates and greatest reduction with Isoniazid preventive therapy (IPT) were among individuals with “inactive” M. tuberculosis infection detected on chest radiography [8], suggesting that an important mechanism of the intervention may have been to reduce reactivation of “inactive” M. tuberculosis infection

Read more

Summary

Introduction

Over the past 15 years, the number of deaths due to tuberculosis has fallen by 22%, but the annual number of incident cases of tuberculosis has remained the same (Figure 1) [1]. These trials evaluated the effect of population-wide IPT following high-coverage active case finding.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call